By E-commerce 4 Internet Marketers Editorial
Analysis. This piece separates documented processor notices and federal timing from interpretation about how high-risk ecommerce operators should plan acquiring. Facts below are attributed to primary or reputable secondary sources. Judgments about underwriting incentives are labeled as analysis.
Square told affected sellers that CBD, hemp, and hemp-derived products will no longer be permitted on its platform for online or in-person sales, according to a merchant email obtained and published by Marijuana Moment on August 7, 2026. That notice directs mixed-catalog businesses to remove those items from Square catalogs by October 15, 2026. The same email cited a federal redefinition effective November 12, 2026.
Congress later delayed most of that federal rewrite. On September 2, 2026, President Trump signed H.R. 6500, the Continuing Appropriations and Extensions Act, 2027, which became Public Law 119-103. Legal analyses from Foley Hoag and contemporaneous industry reporting state that the Act pushes most Section 781 hemp-product restrictions from November 12 to December 11, 2026, while products containing cannabinoids not capable of being naturally produced by a Cannabis sativa L. plant still lose hemp status on November 12. Square’s October 15 catalog instruction precedes both federal dates.
The three calendars operators are juggling
October 15, 2026 (Square catalog removal). Marijuana Moment published Square’s mixed-catalog email directing sellers to remove CBD, hemp, and hemp-derived items from Square catalogs (in-person and online) by October 15, after which those items are not permitted on the platform. The email states that the Square account remains open for non-CBD products to the extent Square policies allow, and that outstanding Square Loan balances and terms are unaffected.
Trade reporting after that publication describes a second notice pattern for hemp-primary businesses, including emails stating account closure on November 5, 2026. That closure wording is not in the mixed-catalog letter Marijuana Moment printed. Operators should follow the notice attached to their own account.
November 12, 2026 (original federal effective date, still relevant for some products). Square’s August email cited November 12 as the federal date. Foley Hoag summarizes the underlying rewrite as limiting legal hemp-THC products to a maximum of 0.4 milligrams of total THC per container and prohibiting certain synthetic cannabinoids. Under P.L. 119-103, Foley Hoag and related reporting say the delay carve-out still allows recriminalization on November 12 for synthetic cannabinoids not capable of being naturally produced by the plant.
December 11, 2026 (deferred federal date for most Section 781 provisions). Foley Hoag states that H.R. 6500 / P.L. 119-103 moves the scheduled federal restrictions on hemp-derived THC products from November 12 to December 11, 2026 for the broader rewrite, granting roughly one additional month for Congress to act on a regulatory framework. Congress.gov records that H.R. 6500 became Public Law No. 119-103 on September 2, 2026.
Analysis why acquirers underwrite ahead of statute hope
Mass-market processors do not underwrite to the most optimistic reading of a continuing resolution. They underwrite to residual portfolio risk, card-brand monitoring, and the cost of being last to exit a category that federal law is narrowing. Square’s spokesperson told Marijuana Moment the company was notifying impacted sellers to ensure compliance with the new law, and when asked whether Square would revise policies if the federal ban were delayed or reversed, said it did not have anything specific to share at that time.
That sequencing is the practical lesson for website owners. A statute date that moves from November 12 to December 11 does not automatically reopen a rail that already required catalog removal on October 15. Merchants who built migration plans only around the federal calendar can lose settlement weeks before the law they were watching takes effect.
State rules add a fourth calendar that is often untethered from Congress. Foley Hoag notes multiple state intoxicating-hemp restrictions on independent timelines. Federal delay language does not, by itself, rewrite those state effective dates.
What a processor-first playbook looks like
- Treat the Square (or other acquirer) notice as the settlement deadline for that MID, independent of headlines about P.L. 119-103.
- Export catalog, customer, and sales data while account access remains available.
- Split SKUs that mainstream POS will no longer settle from SKUs that can stay, and document which products need a specialty MID.
- Operators comparing specialty acquiring for compliant CBD or hemp inventory often review contextual resources such as CBD payment gateways when modeling failover options outside consumer platforms that are exiting the category. Underwriting packets commonly include current certificates of analysis, label photos, age-gate and claims controls, chargeback history, and recent statements. This analysis does not endorse any processor and does not claim any named provider will board a given catalog.
- Model reserve release, refund windows, and recurring billing on the replacement MID before the Square date, not after catalog removal.
- Re-read state shipping and retail rules on their own calendars so a federal delay does not create a false sense of clearance.
Closing
Square’s August 2026 notices set an October 15 catalog deadline for CBD and hemp items, citing a then-stated November 12 federal change, while P.L. 119-103 later deferred most of that rewrite to December 11 and left a November 12 bite for certain non-natural cannabinoids. The analysis for high-risk ecommerce is straightforward. Processor and marketplace deadlines can clear inventory rails before federal statute dates, and operators who plan only to Congress inherit settlement gaps. Read the account-specific notice, stand up specialty acquiring early, and treat statutory delays as separate from private underwriting calendars until the processor says otherwise in writing.